Clinic BBP Bozena Pawelczyk
- Address
- lock Available on a paid plan
Clinic BBP Bozena Pawelczyk - Depression and Sleep Disorders Research
Clinic BBP Bozena Pawelczyk specializes in psychiatric research with a particular focus on mood disorders complicated by sleep disturbances. The center conducts advanced clinical trials evaluating novel therapeutic approaches for patients who have not achieved adequate symptom control with standard antidepressant treatments.
- Major Depressive Disorder with comorbid insomnia symptoms
- Adjunctive pharmacotherapy for treatment-resistant depression
- Long-term relapse prevention in depressive disorders
The clinic has expertise in conducting both short-term efficacy studies and extended follow-up trials to assess relapse prevention in patients with Major Depressive Disorder with Insomnia Symptoms (MDDIS). Their research portfolio includes evaluation of innovative compounds such as seltorexant as adjunctive therapy to traditional SSRI/SNRI antidepressants, focusing on patients who demonstrate inadequate response to current standard treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Janssen Cilag International1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinic BBP Bozena Pawelczyk
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2a trial to evaluate the efficacy and safety of BP1.4979 in adult participants with obsessive compulsive disorder | Bioprojet Pharma | Phase II | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE | 1 | Unknown | 2025-09-19 | 2025-09-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.